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Background: It has been almost a decade since HIV was declared a national disaster in Kenya. Antiretroviral
therapy (ART) provision has been a mainstay of HIV treatment efforts globally. In Kenya, the government started
ART provision in 2003 with significantly scale-up after 2006. This study aims to demonstrate changes in population-
level HIV mortality in two high HIV prevalence slums in Nairobi with respect to the initiation and subsequent scale-
up of the national ART program.
Methods: We used data from 2070 deaths of people aged 15–54 years that occurred between 2003 and 2010 in a
population of about 72,000 individuals living in two slums covered by the Nairobi Urban Health and Demographic
Surveillance System. Only deaths for which verbal autopsy was conducted were included in the study. We divided
the analysis into two time periods: the “early” period (2003–2006) which coincides with the initiation of ART
program in Kenya, and the “late” period (2007–2010) which coincides with the scale up of the program nationally.
We calculated the mortality rate per 1000 person years by gender and age for both periods. Poisson regression was
used to predict the risk of HIV mortality in the two periods while controlling for age and gender.
Results: Overall, HIV mortality declined significantly from 2.5 per 1,000 person years in the early period to 1.7 per
1,000 person years in the late period. The risk of dying from HIV was 53 percent less in the late period compared to
the period before, controlling for age and gender. Women experienced a decline in HIV mortality between the two
periods that was more than double that of men. At the same time, the risk of non-HIV mortality did not change
significantly between the two time periods.
Conclusions: Population-level HIV mortality in Nairobi’s slums was significantly lower in the approximate period
coinciding with the scale-up of ART provision in Kenya. However, further studies that incorporate ART coverage
data in mortality estimates are needed. Such information will enhance our understanding of the full impact of ART
scale-up in reducing adult mortality among marginalized slum populations in Kenya.
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The global HIV epidemic is one of the worst to affect
humanity over the last century [1]. Sub-Saharan Africa
(SSA) has borne the brunt of this epidemic where HIV/
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reproduction in any medium, provided the ordecade −1.8 million deaths occurred in the subcontinent
from HIV/AIDS in 2010 alone [2]. Kenya is one of the
countries in SSA that has suffered significantly from the
burden of HIV. There are about 1.4 million adults living
with HIV in Kenya and the national prevalence was 6.4
percent among adults aged 15 – 49 years in 2008 [3,4].
This is down from the estimated prevalence of between
8 and 10 percent in the late 1990s [5,6] and a prevalence
of about 7 percent in 2002 [7]. Despite this decline,
about 80,000 new HIV infections and 110,000 HIV re-
lated deaths are believed to occur in Kenya yearly [4,6].This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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appear to be disproportionately burdened with HIV com-
pared to men and rural residents [3].
Among urban residents, there is limited knowledge on
the impact of HIV in slum settlements in Kenya and
indeed other countries in SSA, although it is known that
urban averages hide gross intra-urban health inequalities
[8]. Slums are of increasing interest because they are
typically home to majority of urban dwellers in low- and
middle income countries. In Kenya, it is estimated that
between 60 to 70 percent of the urban population re-
sides in slums [9]. These slums are typically underserved
by social amenities such as water and sanitation services
and have limited access to quality preventive and curative
health services. Additionally, slums are characterised by
high levels of poverty, unemployment, and insecurity.
Unfortunately, not much is known about the impact of
HIV mortality among the urban poor who reside in vast
slums across most urban centres in Kenya [10]. It would
be anticipated that slum residents are more adversely
affected by the HIV epidemic than non-slum residents
since they generally fare worse off on other health indi-
cators [8,11]. For example, a sero-prevalence study
conducted in 2008 in two slums in Nairobi among a
sample of 2,000 adults aged 18 years and above, found a
prevalence of 11.5 percent [12]. This figure is almost
double the national average and 1.5 times the prevalence
for the entire Nairobi city [3]. In spite of their disad-
vantaged situation, slum residents in Kenya may have
benefited from local and national HIV prevention and
control initiatives. Kenya is one of 22 countries, out of
the 33 globally, where HIV incidence has declined [2].
This success can be largely attributed to several factors:
the global response (HIV prevention, care, treatment
and impact mitigation) to the epidemic including the
launch of UNAIDS in 1996, the targeting of HIV/AIDS as
one of the Millennium Development Goals in 2000; the
launch of the Global Fund to fight AIDS, TB and Malaria
in 2002; and the announcement of U.S President’s
Emergency Plan for AIDS Relief (PEPFAR) by President
Bush in 2003, among others [13-15]. Locally, the launch
of the National AIDS and STI Control Programme
(NASCOP) and the National AIDS Control Council
(NACC) in 1987 and 1999 respectively were crucial steps
for guiding policy direction and mobilizing resources for
the fight against HIV/AIDS in Kenya [16,17].
Overall however, many resource poor countries like
Kenya rely heavily on foreign aid in their fight against
HIV/AIDS [18]. According to a UNAIDS report, this
high dependence on foreign aid suggests a challenge in
national ownership and sustainability of the HIV re-
sponse in these countries [19]. There is therefore grow-
ing demand by the international community for greater
country ownership of the burden of care and support ofthose infected and affected by HIV/AIDS in such settings.
This is more so in view of the ongoing global economic
downturn as well as emergence of competing health prior-
ities such as the rising burden of non-communicable
diseases [20]. Empirical evidence on the impact of the
HIV response may contribute, among other factors, to in-
creased country ownership among national governments.
One way to demonstrate the impact of the HIV
response is through population-level data on mortality
attributable to HIV/AIDS. Unfortunately, most resource-
poor countries that bear the highest burden of HIV also
lack complete vital registration-type data needed to
generate actual population-level figures such as national
HIV mortality estimates [21-23]. As a result, much of
what is known about population-level mortality in such
settings, are based on statistical modelling and estima-
tion [24-26]. In the absence of vital registration systems
and data on causes of death, Health and Demographic
Surveillance Systems (HDSS) provide a useful platform
for contributing to the understanding of the population-
level mortality. Typically, HDSS monitor and track
demographic and health indicators in a population
within a defined geographic area [27]. Usually, HDSS
collect data on vital events including births, death and
migration within the population under surveillance and at
regular intervals [27]. This paper is based on data from
the Nairobi Urban Health and Demographic Surveillance
System (NUHDSS) in Kenya. This HDSS covers two slums
located in the heart of Nairobi. We analysed data on
mortality and causes of death in the NUHDSS that was
collected between 2003 and 2010.
The period under study, 2003 – 2010, is of particular
significance because it traverses two important mile-
stones. First, the initiation of the national antiretroviral
therapy (ART) program in Kenya occurred just before
2003 and by then, only 5 percent of those needing ART
were receiving treatment [7,28]. Second, in 2006, the
Government of Kenya announced that antiretroviral
drugs would be provided for free in all public hospitals
and health centres nationwide [29]. Since then, the
national coverage of ART has increased significantly.
Public-sector sites providing ART proliferated from 30
in 2004 to over 1000 in 2011 [30,31]. By 2009, the
national coverage of ART was estimated to have reached
70 percent of those needing ART [4]. However, the
World Health Organization (WHO) changed its treatment
guidelines and recommended earlier start to treatment.
Thus, it is estimated that by 2010, only half of all Kenyans
in need of ART were receiving it, going by the government
figures and the new WHO treatment guidelines [32].
Overall therefore, the first four years of our study period
(2003–2006) could be said to coincide with the early
period of the national ART program while the last four
years (2007–2010) coincides with the scaling up of the
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because ART scale-up has been demonstrated in a few
studies in SSA to have an impact on population-level mor-
tality [33-35]. We thus expect that the scaling up of the
national ART program in Kenya could potentially have an
influence on population-level mortality in our study areas.
Ideally, we would have preferred to match the analysis
periods with specific ART coverage milestones and data
from our study area. However, such data is unavailable
mostly because the informal nature of the slums implies
that there are no centrally located public health facilities
serving these communities from which such data could
be obtained. The private-for-profit and non-profit health
facilities serving these settlements have weak health
management information systems and no coordinating
mechanisms to aggregate the data generated. In addition,
some patients are known to seek care far away from
their areas of residence to avoid stigma and hence
facility-based ART coverage data may not accurately
reflect population coverage. Nonetheless, we anticipate
that since our study areas are located in the heart of the
capital city of Kenya, then the study communities could
very well have benefitted from the national ART program.
This study aims to demonstrate changes in population-
level HIV mortality in two high HIV prevalence slums in
Nairobi with respect to the approximate timings of the
initiation and subsequent scale-up of the national ART
program.
Methods
Study area and population
We use cause of death data from 2070 deaths that oc-
curred in the NUHDSS between 2003 and 2010 among
males aged between 15 and 54 years, and females aged
between 15 and 49 years, the age groups most affected by
HIV/AIDS. Since 2002, the African Population and Health
Research Center (APHRC), a regional research institution
head-quartered in Nairobi-Kenya, has been operating
the NUHDSS. The NUHDSS covers the two slums of
Viwandani and Korogocho both located less than 10
kilometres from the Nairobi City centre [36]. Viwandani
and Korogocho occupy an area of 0.45 and 0.52 km2
respectively. In total, the population under surveillance in
both slums is about 72,000 people, living in 28,500 house-
holds, and originating from over 15 ethnic groups [36].
The population in Korogocho is mainly comprised of
long-term settlers engaged in informal employment
such as domestic work, petty trading and casual work.
Viwandani is mainly comprised of semi-skilled labour
migrants working in the neighbouring industrial area.
Cause of death data in the NUHDSS
As part of the activities of the NUHDSS, data on individ-
ual and household core demographic events includingbirth, death, in-migration, and out-migration are collected
at four-monthly intervals known as data collection rounds.
These data are collected by trained field interviewers
drawn from the study area and who have a minimum of a
high school certificate or 12 years of formal schooling.
These field interviewers identify and interview key infor-
mants, usually the head of the household or other adult
member of the household, who provide information about
the status of all known household members listed in the
last visit and any visitors to the household since the last
visit. As many as three repeat visits are made by the field
interviewers to locate a ‘credible respondent’ after which
the status of the household members is updated as
“unknown” for that round, if an interview cannot be done.
Additionally, the NUHDSS integrates the Verbal Aut-
opsy (VA) process for ascertaining cause of death. VA is
the process of retrospectively interviewing the primary
caregivers of recently deceased persons in order to gain
an understanding about the circumstances surrounding
and leading up to death [37]. VA can be used to provide
information on causes of death in resource-constrained
settings where vital registration systems are often incom-
plete or non-existent. Details of this process in the
NUHDSS have been published elsewhere [37,38]. In brief,
trained interviewers visit a household, on average within
three months after a death has occurred, to conduct a ver-
bal autopsy interview with a credible respondent –usually
a spouse or other close family member who would be
aware of the circumstances surrounding death. The inter-
view is conducted using a semi-structured data collection
tool that mostly inquires about probable symptoms and
signs that the deceased may have portrayed before death.
The completed tools are then passed to a pair of physi-
cians who independently review each case and assign a
probable cause of death based on WHO International
Statistical Classification of Diseases and Related Health
Problems (ICD-10) [39]. The causes of death assigned by
each physician are then compared and those cases that are
in agreement are recorded as the final causes of death. If
there are any ‘disagreements’ the physicians meet and hold
a consensus meeting arbitrated by a third physician.
Where there is no agreement even after this meeting, such
cases are coded at “indeterminate”. The cause of death
data used for this paper was retrospectively reviewed by
two pairs of physicians over a period of about one month
from August to September 2011. Prior to this, each phys-
ician received three-days of training in ICD-10 coding.
Period effect analysis
All analyses were performed using STATA Statistical
Software Release 11 (StataCorp LP, College Station, Texas,
US). HIV- and all-cause mortality was calculated by
aggregating deaths and person-years of observation for the
two periods: 2003–2006 (early) and 2007–2010 (late).
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living in the NUHDSS area. Residents stopped contribut-
ing time if they out-migrated and resumed contributing if
they re-entered the NUHDSS area. Mortality rates by gen-
der and age group were computed and compared for the
early and late periods. Additionally, a Poisson regression
model was used to estimate and compare the incidence
(mortality) risk ratio or IRR (for all-cause and HIV
mortality) between the two periods, while controlling for
age and gender. In the regression model, we modelled the
counts of deaths as a function of select individual-level
characteristics –age, gender and period using the offset of
person years.
In order to determine if any potential changes in mor-
tality between the two observation periods could have
been attributable to an underlying change in the popula-
tion structure, we standardized mortality rates between
the two observation periods using the un-weighted aver-
age of the two population compositions as the standard.
To do this, first the percent distribution for each period,
and then the average percent by gender and age categories
were computed. Decomposition of the difference between
the two period rates into a part due to compositional
differences and a part due to differences in rates was done,
using the dstdize command in STATA which uses a
weighted average of the two populations as the standard.
A Poisson regression-based standardization for count data
was also necessary to control for differences in compos-
itional variables such as gender and age. This analysis
yielded the changes in all-cause, HIV and non-HIV mor-
tality between the two periods, the differences of which
would not be explained by changes in underlying popula-
tion structure between the two periods.
Missing or indeterminate causes of death
Overall there were 2070 deaths of which 560 (27%) deaths
were classified as indeterminate or missing. In the previ-
ously described analyses, indeterminate or missing causes
of death were classified as ‘non-HIV’. However, an imput-
ation model was applied to distribute missing or indeter-
minate cause of death data to various causes of death. We
derived an imputation model for cause-of-death that
included the variables of sex, age, slum and year of death.
The variable year was included in the model to capture
any trends in mortality for different causes of death. This
imputation model was implemented using STATA’s ice
program which uses Multiple Imputations by Chained
Equations (MICE) [40]. This approach creates multiple
imputations as opposed to single imputation and this
helps account for statistical uncertainty in imputation.
Ethical considerations
We utilised routine data collected every four months as
part of the NUHDSS. In order to operate the NUHDSS,APHRC applied for, and received approval from the
Kenya Medical Research Institution’s National Ethics
Review Committee (KEMRI/NERC). All VA data gener-
ated from the NUHDSS is treated as strictly confidential
and access is not granted to anyone outside of the research
team except in accordance with APHRC’s data sharing
policy [41].
Results
Mortality rates
All cause vs. HIV mortality
All-cause mortality declined from 6.7 deaths per 1000
person years (PY) in the early period to 6.1 in the late
period (Table 1). Although women had a higher mortality
rate in the early period compared to men (7.5 versus 6.1
deaths per 1000 PY respectively), they showed an overall
larger decline in all-cause mortality rate (25 percent
reduction or 1.9 deaths per 1000 PY) between the early
and late period. For men, all-cause mortality increased
slightly by 6.5 percent (or 0.4 deaths per 1000 PY) between
the early and late period. All-cause mortality also declined
in the late period across all age-groups with the largest
decline seen in the 35–44 years age-group.
HIV mortality declined significantly from 2.5 deaths
per 1000 PY in the early period to 1.7 deaths per 1000
PY in the late period (or a 32 percent reduction). HIV
mortality was almost double among females (3.5 deaths
per 1000 PY) in the early period compared with men
(1.9 per 1000 PY). However, HIV mortality declined by
43 percent between the early and late period among
women compared to a decline of 16 percent for men
during the same period. This significantly reduced the
gender gap in HIV mortality in the late period.
Consistent with the age profile of HIV prevalence in
most sub-Saharan African countries, HIV mortality
increased with age in both the early and late periods.
However, in the late period, HIV mortality was cut by
half in the youngest age group (15–24) and by 41
percent in the age-group 25–34 compared to declines of
22–26 percent in the older age groups.
Period effect on mortality
Using Poisson regression, the period effect on all-cause,
HIV and non-HIV related mortality was assessed, con-
trolling for age and gender. The results are shown in
Table 2. Males had an 18 percent lower risk of dying
from all-causes compared with females (p < 0.0001). The
IRR from all-cause mortality increased linearly with age
and this was true for both males and females. In all in-
stances, the differences in IRR by age were statistically
significant. There was 14 percent reduction in IRR from
all-cause mortality in the late period compared to the
early one, controlling for age and gender (p < 0.0001).
These declines appeared to have been driven exclusively
Table 1 All-cause and HIV related mortality rates by period, gender and age group
All-cause mortality HIV related mortality
2003 - 2006 2007 - 2010 2003 - 2006 2007 - 2010
Person
years
Deaths Mortality
Rate
Person
years
Deaths Mortality
rate
Change in
rate
Person
years
Deaths Mortality
rate
Person
years
Deaths Mortality
rate
Change in
rate
Overall 158472.7 1057 6.7 165110.5 1013 6.1 −0.6 158472.7 398 2.5 165110.5 287 1.7 −0.8
Gender
Female 64458.3 483 7.5 69285.8 386 5.6 −1.9 64458.3 224 3.5 69285.8 138 2.0 −1.5
Male 94014.4 574 6.1 95824.6 627 6.5 0.4 94014.4 174 1.9 95824.6 149 1.6 −0.3
Age
group
15-24 56656.6 174 3.1 54497.3 152 2.8 −0.3 56656.6 43 0.8 54497.3 21 0.4 −0.4
25-34 62350.5 411 6.6 64458.7 380 5.9 −0.7 62350.5 168 2.7 64458.7 102 1.6 −1.1
35-44 27950.4 308 11.0 31882.7 310 9.7 −1.3 27950.4 129 4.6 31882.7 108 3.4 −1.2
45-54 11515.1 164 14.2 14271.8 171 12.0 −2.3 11515.1 58 5.0 14271.8 56 3.9 −1.1
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Table 2 Incidence risk ratios for all-cause and HIV related mortality rates by time period
All-cause deaths HIV-related deaths
Overall p-value Female p-value Male p-value Overall p-value Female p-value Male p-value
Male (ref: Female) 0.82 *** - - - - 0.44 *** - - - -
Age (ref: 15–24)
25-34 2.22 *** 3.17 *** 1.59 *** 3.00 *** 3.00 *** 3.24 ***
35-44 3.77 *** 5.11 *** 2.84 *** 5.36 *** 4.78 *** 6.76 ***
45-54 4.83 *** 6.14 *** 3.76 *** 5.65 *** 4.06 *** 8.16 ***
2007-2010 (ref: 2003–2006) 0.86 ** 0.68 *** 1.02 0.784 0.47 *** 0.48 *** 0.47 ***
**p<0.001, ***p<0.0001.
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cent in the late period compared to that of males which
increased marginally by 2 percent between the early and
late periods.
For HIV mortality, IRR was 56 percent lower in males
compared with females over the entire period. IRR from
HIV mortality among males increased with advancing
age, whereas for females, the IRR from HIV mortality
was highest in the 35–44 years age group. The risk of
dying from HIV was 53 percent lower in the late period
compared with the early period, controlling for age and
gender. This risk reduction was similar for both males
and females at 53 and 52 percent respectively.
Period-standardization effect on mortality
Table 3 shows the period-standardized mortality rates
and IRR for all-cause, HIV- and non-HIV mortality by
observation period. Of particular note is the finding thatTable 3 Period-standardized mortality rates for all-cause, HIV
All cause mortality
2003- 2006 2007-2
Overall mortality 6.7 6.1
Gender Male 3.6 3.8
Female 3.0 2.3
Age
15-24 1.1 0.9
25-34 2.6 2.3
35-44 2.0 1.9
45-54 1.0 1.0
Regression based standardization
IRR (p-valu
Female 1.22 ***
25-34 2.19 ***
35-44 3.67 ***
45-54 4.68 ***
2007-2010 0.88 ***
***p < 0.0001.on one hand, HIV mortality declined in the late period
for males, females, and across all age groups. However,
on the other hand, non-HIV mortality either increased
or remained the same except among females where it
declined marginally. Further, the IRR for all-cause
mortality was significantly reduced by 12 percent in the
late period. Whereas the HIV mortality risk was 35
percent less in the late period (p < 0.0001). Finally, the
risk of non-HIV mortality did not change significantly in
the late period.
Discussion
We set out to determine if there is any evidence of
reduction in population-level HIV mortality among a
population of slum dwellers living in areas covered by a
health and demographic surveillance system in Nairobi,
over a period that coincides with the initiation and mass
scale-up of the national ART program in Kenya. Overall,-related and non-HIV mortality
HIV related mortality Non-HIV mortality
010 2003- 2006 2007-2010 2003- 2006 2007-2010
3.3 2.3 3.4 3.8
1.4 1.0 2.2 2.8
1.9 1.3 1.1 1.0
0.4 0.2 0.7 0.7
1.4 0.8 1.2 1.5
1.1 0.9 0.9 1.0
0.5 0.4 0.5 0.6
e) IRR (p-value) IRR (p-value)
2.34 *** 0.70 ***
3.85 *** 1.56 ***
7.58 *** 2.28 ***
8.78 *** 3.19 ***
0.65 *** 1.10
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the late period (2007–2010) that coincided with the scal-
ing up of the national ART program in Kenya compared
with the early period (2003–2006) just following the
commencement of the program. This decline occurred
despite the very high prevalence of HIV in the study
community, 11.5 percent in 2008 [12] and high mortality
that have been previously attributable to HIV [38].
Recent work in South Africa and Malawi have shown
decline in mortality at the population level following the
scale-up of ART in the study populations [33,34]. Like
both of these studies, our study was conducted using
mortality data from surveillance of a large population
and the timing of the decline in mortality coincides with
the scale up of ART.
However, unlike both of these studies, the lack of ART
coverage and uptake data specific to our study areas is a
major limitation to our study. We also lack data on
treatment initiation which may have an impact on mor-
tality with or without ART scale up. Overall, we have
had to rely on the timelines of ART scale-up nationally.
In spite of this limitation, it is plausible that the decline
in population-level mortality in our study area could be
attributable to the national ART scale-up program. This
is because overall trends in mortality in the surveillance
areas show that, apart from HIV-related causes, all other
causes of death were either stable or increased over the
eight years covered by our analysis. In addition, we are
not aware of any other major health interventions in the
study area during the period covered by our analysis.
More importantly, reduction in HIV mortality in the late
period was more than double the reduction in all-cause
mortality. Given the significant declines in the late
period of the risks of all-cause mortality and HIV mor-
tality, as well the lack of change in the risk of non-HIV
-related deaths, we can infer that the observed declines
in overall mortality in the late period is due largely from
the declines in HIV-related deaths. And we believe that
this decline in HIV deaths is most likely due to the
scaling up of ART in public health facilities in Kenya just
after 2006.
Another interesting finding from our study was that
declines in HIV mortality were much larger for women
than for men. Specifically, it was 2.7 times larger for
females than for males ((1.5/3.5 = 42.86%) / (0.3/1.9 =
15.79%) = 2.7). This was dissimilar to the findings of the
study in rural South Africa where approximate declines
in HIV mortality of 22 percent and 29 percent was ob-
served in adult women and men respectively. The study
in Malawi did not find any gender differences in mortality
reduction. In our study, the excess female disadvantage in
HIV-related deaths reduced from 84 percent in the early
period to only 25 percent in the late period (see Table 1).
This observed reduction in excess female mortality in thelate period could suggest that gender inequities in HIV-
related deaths are being successfully addressed by HIV
control programs such as the national ART scale-up
program in Kenya. On the other hand, we found that
all-cause mortality for men increased slightly in the late
period. This might be attributable to the observation that
injuries and accidents, which account for the largest
proportion of deaths among adult male residents in the
slum area, actually increased over the entire study period
as the competing risk from HIV declined. In terms of age
differentials, we found the largest drop (50 percent) in
HIV-related deaths among younger people aged 15–24
years. This is a very important finding in this setting since
younger adults are more likely to be unemployed and
hence less likely to afford treatment compared to older
persons. The finding could mean that the relatively wide
scale provision of free ART in the late period was particu-
larly beneficial to this age group.
Aside from the lack of data on ART coverage and up-
take, our study has a few other limitations. First, we do
not have mortality data prior to 2003 so we were unable
to determine the effect of secular trends on our results.
However, available estimates for Kenya show that since
1990, AIDS deaths have been on an upward trajectory
until after 2005 [42]. Also, we could not conduct a sensi-
tivity analysis for our verbal autopsy data so it is impos-
sible to say that the observed changes were not due to
misclassification of HIV deaths. To perform a sensitivity
analysis we would need either sero-prevalence data among
those in the study or health facility data. However, the only
sero-prevalence study in the area was done towards the
end our study period in 2008 [12]. We attempted to ‘ver-
ify’ deaths attributed to HIV according to VA by analysing
data for those individuals who had participated in the
sero-prevalence study and who had died within the study
period. There were 61 of such cases −25 people or 41
percent of those who died were previously diagnosed as
HIV positive. The sensitivity of VA in ‘diagnosing’ HIV
deaths among those who were known HIV positive was 64
percent (16 HIV deaths out of 25 HIV positive persons).
The specificity of VA in diagnosing non-HIV deaths
among those who were HIV negative was 81 percent (29
non-HIV deaths out of 36 HIV negative persons). These
findings are consistent with previous studies which have
shown that verbal autopsies are considerably valid in
detecting HIV deaths especially among adults though
underestimation of HIV deaths is not uncommon
[43-45]. Generally, the accuracy of verbal autopsies
interpreted by physicians is said to have an acceptable
level of diagnostic accuracy, at the population level, if
sensitivity and specificity are at least 50 percent and 90
percent respectively [46].
One other potential limitation of our study is that the
absence of sero-prevalence data for the period under
Table 4 Open cohort of females aged 15–49 years and males aged 15 – 54 years, 2003–2010, NUHDSS
Females aged 15 - 49 2003 2004 2005 2006 2007 2008 2009 2010
Population at start of year 12686 14566 13983 14777 15219 15360 16318 17569
Entered age group during year 313 330 340 293 390 345 365 386
In-migrated (from outside *DSA) during year 4199 4620 4134 3700 3456 4048 4551 4086
Died during year 153 118 106 108 86 88 91 119
Exited age group during year 83 55 68 69 101 86 168 69
Lost to follow-up during year (out-migrations) 3125 5824 3650 3465 3770 3363 3525 3907
Total person time contributed each year 16191.3 16118.1 16663.6 17086.0 17527.0 17702.3 19789.4 19989.1
**Out-migration rates 0.19 0.36 0.22 0.20 0.22 0.19 0.18 0.20
Males aged 15 - 54 2003 2004 2005 2006 2007 2008 2009 2010
Population at start of year 20245 22389 21019 21721 22021 22152 23116 24434
Entered age group during year 324 335 371 301 372 314 331 386
In-migrated (from outside *DSA) during year 4997 5658 4767 4545 4478 5107 5679 5121
Died during year 158 161 125 130 160 136 153 178
Exited age group during year 106 136 71 227 111 173 124 164
Lost to follow-up during year (out-migrations) 4259 7980 4528 4300 4653 4363 4480 4866
Total person time contributed each year 24371.4 23708.8 24169.6 24393.4 24874.4 25288.1 27321.2 27680.4
**Out-migration rates 0.17 0.34 0.19 0.18 0.19 0.17 0.16 0.18
*DSA Demographic Surveillance Area.
**Out-migration rates were calculated by dividing the number of persons who out-migrated each year by the total person years contributed by those present at
the start of the year and those who in-migrated during the year.
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http://www.biomedcentral.com/1471-2458/13/588study makes it impossible to determine if the observed
findings were due to any differential out-migration of
HIV positive persons from the slum areas. The study in
South Africa did not find any evidence of differential
out-migration between HIV positive persons, HIV nega-
tive persons and those whose HIV status was unknown.
We do not have any reason to believe that there was any
differential migration in our study area during the study
period. Further, the overall trends in out-migration rates
remained fairly stable in the study area over both the
early and late periods (see Table 4). This is with the0
5
10
15
20
25
Figure 1 Plot showing imputed versus original causes of death, NUHDexception of 2004 when there was forceful demolition by
local authorities of slum structures built near railway
lines and under main power lines in one of the slums.
Again, about 27 percent of all deaths in this study
were not successfully coded or assigned a cause of death,
that is, either the physicians were unable to arrive at a
consensus on the causes of death, or there was no cred-
ible respondent available to conduct a VA interview. To
determine the impact of this on our findings, we applied
an imputation model to causes of death as described in
the methods section of this paper. Overall, the pattern ofOriginal
Imputed
SS 2003 – 2010.
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http://www.biomedcentral.com/1471-2458/13/588cause-specific mortality for the imputed model did not
differ significantly from that in which the causes of death
are known (see Figure 1). We went further to estimate
the mortality rates in the early and late periods using the
imputed data (see Additional file 1). The trends in HIV
mortality in the early and late period using the imputed
data were similar to the trends described previously for
the original data.
The major strength of our study is the large number
of cases considered in the analysis. This is borne out of
the advantage provided by a health and demographic
surveillance system in that it captures all deaths, births
and migrations within the study area. Hence the status
(dead or alive) of the total population at any time point
is known and can thus contribute to the numerators and
denominators used in calculating mortality rates. Further,
demographic surveillance often utilise VA to obtain
cause-specific mortality data in the population under
surveillance. This is even more crucial in populations
where majority of deaths occur outside a health facility
and hence analysis based on hospital/health facility data
will not give a complete or accurate picture of the
mortality profile in the general population. About 70
percent of deaths in the study population occur outside
a health facility (APHRC, unpublished data).
Conclusion
In conclusion, while HIV/AIDS remains a major cause
of death among the urban poor as compared to other
causes of mortality, there is evidence that HIV mortality
has decreased significantly at the population level, and,
this decline corresponds with the estimated period of
scaling up of the national ART program in Kenya. The
slums of Nairobi have limited access to quality health
care and exhibit a higher HIV prevalence compared to
the national or city-level estimates. Despite their disad-
vantaged position, slum residents seem to have benefited
from the public sector scale-up of ART. We recommend
further studies that incorporate ART coverage data in
mortality estimates where available. Such information
will enhance our understanding of the full impact of
ART scale-up in reducing adult mortality among mar-
ginalized slum populations.
Additional file
Additional file 1: All-cause and HIV-related mortality rates by
period, gender and age group (after imputation).
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